Series stock is trading -18.88% below its average target price of $87.25 after dropping -1.5% during today's morning session. Analysts are giving the Large-Cap Medical Electronics company an average rating of buy and target prices ranging from $73.0 to $110.0 per share.
Series's short interest — meaning the percentage of the share float that is being shorted — is lower than average at 1.9%. The stock's short ratio is 0.99. The company's insiders own 0.27% of its outstanding shares, which indicates a strong alignment between management and shareholder interests.
Another number to watch is the company's rate of institutional share ownership, which now stands at 87.0%. In conclusion, we believe there is mixed market sentiment regarding Series.
Institutions Invested in Series
| Date Reported | Holder | Percentage | Shares | Value |
|---|---|---|---|---|
| 2025-03-31 | Vanguard Group Inc | 11% | 51,403,855 | $3,638,364,794 |
| 2025-03-31 | Capital Research Global Investors | 11% | 51,195,068 | $3,623,586,850 |
| 2025-03-31 | Blackrock Inc. | 8% | 38,232,134 | $2,706,070,397 |
| 2025-03-31 | State Street Corporation | 4% | 19,287,987 | $1,365,203,696 |
| 2025-03-31 | Dodge & Cox Inc | 4% | 16,585,509 | $1,173,922,306 |
| 2025-03-31 | Geode Capital Management, LLC | 3% | 11,713,105 | $829,053,557 |
| 2025-03-31 | Invesco Ltd. | 2% | 7,978,041 | $564,685,732 |
| 2025-03-31 | Citadel Advisors Llc | 2% | 6,916,540 | $489,552,692 |
| 2025-03-31 | Morgan Stanley | 1% | 6,447,253 | $456,336,559 |
| 2024-12-31 | NORGES BANK | 1% | 6,248,800 | $442,290,056 |
